Advancing the Vaccine Law Dialogue
Virtual Conference
- National Vaccine Law Conference: Speakers, Presenters, and Panelists
The 2025 National Vaccine Law Conference has been convened to continue our work of addressing the urgent need for an increased understanding in many sectors of the operations of different aspects of vaccine, vaccination, and immunization law.
Speakers for the 2025 conference are being determined.
Those scheduled to speak or present at the 2023 conference included:
- Tommy Acciani, PhD, Director, U.S. Vaccine Policy, Glaxosmithkline
- Daniel Berry, JD, Principal Deputy General Counsel, U.S. Department of Health & Human Services (HHS)
- Katherine Bliss, PhD, Senior Fellow and Director, Immunizations and Health Systems Resilience, Global Health Policy Center, Center for Strategic & International Studies, Adjunct Professor, Georgetown University
- Abby Bownas, Partner and Coalition Manager, Adult Vaccine Access Coalition
- Darlene Huang Briggs, JD, MPH, Deputy Director, Act for Public Health Initiative, Network for Public Health Law
- Cathy Burgess, JD, Partner, Alston & Bird
- Heather Burris, ME, Division Chief, District of Columbia Department of Public Health
- Hon. Patricia E. Campbell-Smith, Chief Judge, United States Court of Federal Claims (USCFC)
- James Daniels, MPH, Lead State and Local Public Health at Amazon Web Services
- Maggie Davis, JD, MBE, PMP, Director, State Health Policy, ASTHO, Fellow, Emerging Leaders in Biosecurity Initiative, Johns Hopkins Center for Health Security
- Leah Durant, Owner and Principal Attorney of the Law Offices of Leah V. Durant, PLLC
- Laura Fox, MD, Clinical Assistant Professor of Emergency Medicine, The George Washington University College of Medicine
- Sonali Gunawardhana, JD, LLM, MPH Assistant General Counsel, Regulatory Cardinal Health
- Wanda Hill, RPh, JD, Vice President, Regulatory Affairs (US), GlaxoSmithKline (GSK)
- Meghan Jendrysik, PhD, Managing Editor, Elsevier, Fellow, NIH
- Charley John, PharmD, Senior Director, Healthcare Policy & Strategy, Walgreen Co.
- David Kim, MD, CAPT, U.S. Public Health Service, Director, National Vaccine Program Division, Office of Infectious Disease & HIV/AIDS Policy, U.S. HHS
- Candace Lerman, JD, MS, HCC, Attorney, Adheris Health, Patient Advocate, RareCandace.com
- Alexa McKinley, JD, Regulatory Affairs Manager, National Rural Health Association
- Rachel Mitrovich, JD, Director of Global vaccines and Public Policy at Merck
- Kelly Moore, MS, PhD, CEO, Immunize.org
- Hon. Pauline Newman, Judge of the United States Court of Appeals for the Federal Circuit
- Heather Pearlman, JD, Deputy Director of the Constitutional and Specialized Torts Branch U.S. Department of Justice’s Civil Division
- Amy Pisani, MA, CEO, Vaccinate Your Family
- Elizabeth Platt, JD, Director of Research and Operations, Center for Public Health Law Research, Beasley School of Law, Temple University
- Institutes
- Julian Ritchey, MBA, Vice President, Head of Public Affairs & Patient Advocacy, US Vaccines, Sanofi
- Jessica Malaty Rivera, MS, Science Communication Lead, The COVID Tracking Collective, The Rockefeller Foundation COVID Tracker
- Sara Rosenbaum, JD, Professor Emerita, Health Law and Policy, The George Washington University, Milken Institute School of Public Health
- Jeanne Santoli, MD, MPH, Branch Chief, Vaccine Supply and Assurance, National Center for Immunization and Respiratory Diseases, CDC
- Harald Schmidt, Assistant Professor of Medical Ethics & Health Policy, School of Medicine, University of Pennsylvania
- Secretary Donna Shalala, PhD, Trustee Professor of Political Science and Health Policy at the University of Miami
- Kasia Shaw, FNP-C, Sr. Director of Medical Respite and Nursing Services, PathForward
- Julissa Soto, Commissioner, Health Equity Commission for the Colorado Department of Public Health, CEO and Founder, Julissa Soto Latino Health Equity Consulting
- Lauren Sullivan, JD, Associate General Counsel, Bill & Melinda Gates Foundation
- Timothy M. Westmoreland, JD, Professor Emeritus, Georgetown Law
The 2023 Conference Agenda will be available HERE.
Speaking or presenting at the 2023 conference:
Those currently committed to speak or present at the 2023 National Vaccine Law Conference include:
Brian Dean Abramson, Esq.
Author, Vaccine, Vaccination, & Immunization Law, Adjunct Professor of Vaccine Law, FIU College of Law
Tommy Acciani, PhD
Director, U.S. Vaccine Policy, Glaxosmithkline
Michael R. Anderson, MD
Pediatric Critical Care Physician
Lindsay Androski
Special Counsel to Genevant Sciences and Adjunct Professor of Pharmacy at the University of North Carolina at Chapel Hill
Brian Dean Abramson
Author, Vaccine, Vaccination, & Immunization Law, Adjunct Professor of Vaccine Law, FIU College of Law
Michael R. Anderson
MD, Pediatric Critical Care Physician
Phyllis Arthur
MBA, Vice President for Infectious Diseases and Diagnostics Policy at the Biotechnology Innovation Organization
Alexandra A. Bhatti
JD, MPH, Director of U.S. Vaccine Policy at Merck & Co. Inc
Brian Dean Abramson
Author, Vaccine, Vaccination, & Immunization Law, Adjunct Professor of Vaccine Law, FIU College of Law
Michael R. Anderson
MD, Pediatric Critical Care Physician
Phyllis Arthur
MBA, Vice President for Infectious Diseases and Diagnostics Policy at the Biotechnology Innovation Organization
Alexandra A. Bhatti
JD, MPH, Director of U.S. Vaccine Policy at Merck & Co. Inc
Brian Dean Abramson
Author, Vaccine, Vaccination, & Immunization Law, Adjunct Professor of Vaccine Law, FIU College of Law
Michael R. Anderson
MD, Pediatric Critical Care Physician
Phyllis Arthur
MBA, Vice President for Infectious Diseases and Diagnostics Policy at the Biotechnology Innovation Organization
Alexandra A. Bhatti
JD, MPH, Director of U.S. Vaccine Policy at Merck & Co. Inc
Brian Dean Abramson
Author, Vaccine, Vaccination, & Immunization Law, Adjunct Professor of Vaccine Law, FIU College of Law
Michael R. Anderson
MD, Pediatric Critical Care Physician
Phyllis Arthur
MBA, Vice President for Infectious Diseases and Diagnostics Policy at the Biotechnology Innovation Organization
Alexandra A. Bhatti
JD, MPH, Director of U.S. Vaccine Policy at Merck & Co. Inc
Brian Dean Abramson
Author, Vaccine, Vaccination, & Immunization Law, Adjunct Professor of Vaccine Law, FIU College of Law
Michael R. Anderson
MD, Pediatric Critical Care Physician
Phyllis Arthur
MBA, Vice President for Infectious Diseases and Diagnostics Policy at the Biotechnology Innovation Organization
Alexandra A. Bhatti
JD, MPH, Director of U.S. Vaccine Policy at Merck & Co. Inc
Brian Dean Abramson
Author, Vaccine, Vaccination, & Immunization Law, Adjunct Professor of Vaccine Law, FIU College of Law
Michael R. Anderson
MD, Pediatric Critical Care Physician
Phyllis Arthur
MBA, Vice President for Infectious Diseases and Diagnostics Policy at the Biotechnology Innovation Organization
Alexandra A. Bhatti
JD, MPH, Director of U.S. Vaccine Policy at Merck & Co. Inc
Brian Dean Abramson
Author, Vaccine, Vaccination, & Immunization Law, Adjunct Professor of Vaccine Law, FIU College of Law
Michael R. Anderson
MD, Pediatric Critical Care Physician
Phyllis Arthur
MBA, Vice President for Infectious Diseases and Diagnostics Policy at the Biotechnology Innovation Organization
Alexandra A. Bhatti
JD, MPH, Director of U.S. Vaccine Policy at Merck & Co. Inc
Brian Dean Abramson
Author, Vaccine, Vaccination, & Immunization Law, Adjunct Professor of Vaccine Law, FIU College of Law
Michael R. Anderson
MD, Pediatric Critical Care Physician
Phyllis Arthur
MBA, Vice President for Infectious Diseases and Diagnostics Policy at the Biotechnology Innovation Organization
Alexandra A. Bhatti
JD, MPH, Director of U.S. Vaccine Policy at Merck & Co. Inc
Brian Dean Abramson
Author, Vaccine, Vaccination, & Immunization Law, Adjunct Professor of Vaccine Law, FIU College of Law
Michael R. Anderson
MD, Pediatric Critical Care Physician
Phyllis Arthur
MBA, Vice President for Infectious Diseases and Diagnostics Policy at the Biotechnology Innovation Organization
Alexandra A. Bhatti
JD, MPH, Director of U.S. Vaccine Policy at Merck & Co. Inc
Brian Dean Abramson
Author, Vaccine, Vaccination, & Immunization Law, Adjunct Professor of Vaccine Law, FIU College of Law
Michael R. Anderson
MD, Pediatric Critical Care Physician
Phyllis Arthur
MBA, Vice President for Infectious Diseases and Diagnostics Policy at the Biotechnology Innovation Organization
Alexandra A. Bhatti
JD, MPH, Director of U.S. Vaccine Policy at Merck & Co. Inc
Brian Dean Abramson
Author, Vaccine, Vaccination, & Immunization Law, Adjunct Professor of Vaccine Law, FIU College of Law
Michael R. Anderson
MD, Pediatric Critical Care Physician
Phyllis Arthur
MBA, Vice President for Infectious Diseases and Diagnostics Policy at the Biotechnology Innovation Organization
Alexandra A. Bhatti
JD, MPH, Director of U.S. Vaccine Policy at Merck & Co. Inc
Brian Dean Abramson
Author, Vaccine, Vaccination, & Immunization Law, Adjunct Professor of Vaccine Law, FIU College of Law
Michael R. Anderson
MD, Pediatric Critical Care Physician
Phyllis Arthur
MBA, Vice President for Infectious Diseases and Diagnostics Policy at the Biotechnology Innovation Organization
Alexandra A. Bhatti
JD, MPH, Director of U.S. Vaccine Policy at Merck & Co. Inc